BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lymphoma AND CDKN1B, CDKN4, 1027, ENSG00000111276, MEN4, P27KIP1, P46527, MEN1B, KIP1 AND Prognosis
36 results:

  • 1. XPO1 blockade with KPT-330 promotes apoptosis in cutaneous T-cell lymphoma by activating the p53-p21 and p27 pathways.
    Chakravarti N; Boles A; Burzinski R; Sindaco P; Isabelle C; McConnell K; Mishra A; Porcu P
    Sci Rep; 2024 Apr; 14(1):9305. PubMed ID: 38653804
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. [Efficacy and prognosis of newly diagnosed multiple myeloma patients treated with bortezomib, lenalidomide and dexamethasone].
    Xu JY; Yan WW; Fan HS; Liu JH; Du CX; Deng SH; Sui WW; Xu Y; Qiu LG; An G
    Zhonghua Yi Xue Za Zhi; 2022 Aug; 102(30):2338-2344. PubMed ID: 35970791
    [No Abstract]    [Full Text] [Related]  

  • 3. Glans metastatic extra-nodal natural killer/T-cell lymphoma, nasal-type with HDAC inhibitor as maintenance therapy: a rare case report with literature review.
    Fu C; Yang C; Li Q; Wang L; Zou L
    Ann Palliat Med; 2020 Sep; 9(5):3602-3608. PubMed ID: 32527129
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Antitumor effect of baicalin from the Scutellaria baicalensis radix extract in B-acute lymphoblastic leukemia with different chromosomal rearrangements.
    Orzechowska BU; Wróbel G; Turlej E; Jatczak B; Sochocka M; Chaber R
    Int Immunopharmacol; 2020 Feb; 79():106114. PubMed ID: 31881375
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Silencing of DYRK2 increases cell proliferation but reverses CAM-DR in Non-Hodgkin's lymphoma.
    Wang Y; Wu Y; Miao X; Zhu X; Miao X; He Y; Zhong F; Ding L; Liu J; Tang J; Huang Y; Xu X; He S
    Int J Biol Macromol; 2015 Nov; 81():809-17. PubMed ID: 26341817
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Curcumin induces apoptosis in pancreatic cancer cells through the induction of forkhead box O1 and inhibition of the PI3K/Akt pathway.
    Zhao Z; Li C; Xi H; Gao Y; Xu D
    Mol Med Rep; 2015 Oct; 12(4):5415-22. PubMed ID: 26166196
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. High-dose cytarabine does not overcome the adverse prognostic value of CDKN2A and TP53 deletions in mantle cell lymphoma.
    Delfau-Larue MH; Klapper W; Berger F; Jardin F; Briere J; Salles G; Casasnovas O; Feugier P; Haioun C; Ribrag V; Thieblemont C; Unterhalt M; Dreyling M; Macintyre E; Pott C; Hermine O; Hoster E;
    Blood; 2015 Jul; 126(5):604-11. PubMed ID: 26022239
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Copy number genome alterations are associated with treatment response and outcome in relapsed childhood ETV6/RUNX1-positive acute lymphoblastic leukemia.
    Bokemeyer A; Eckert C; Meyr F; Koerner G; von Stackelberg A; Ullmann R; Türkmen S; Henze G; Seeger K
    Haematologica; 2014 Apr; 99(4):706-14. PubMed ID: 24241490
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Expression of Spy1 protein in human non-Hodgkin's lymphomas is correlated with phosphorylation of p27 kip1 on Thr187 and cell proliferation.
    Hang Q; Fei M; Hou S; Ni Q; Lu C; Zhang G; Gong P; Guan C; Huang X; He S
    Med Oncol; 2012 Dec; 29(5):3504-14. PubMed ID: 22492278
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Twenty-one cases of blastic plasmacytoid dendritic cell neoplasm: focus on biallelic locus 9p21.3 deletion.
    Lucioni M; Novara F; Fiandrino G; Riboni R; Fanoni D; Arra M; Venegoni L; Nicola M; Dallera E; Arcaini L; Onida F; Vezzoli P; Travaglino E; Boveri E; Zuffardi O; Paulli M; Berti E
    Blood; 2011 Oct; 118(17):4591-4. PubMed ID: 21900200
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Diffuse large B-cell lymphomas with CDKN2A deletion have a distinct gene expression signature and a poor prognosis under R-CHOP treatment: a GELA study.
    Jardin F; Jais JP; Molina TJ; Parmentier F; Picquenot JM; Ruminy P; Tilly H; Bastard C; Salles GA; Feugier P; Thieblemont C; Gisselbrecht C; de Reynies A; Coiffier B; Haioun C; Leroy K
    Blood; 2010 Aug; 116(7):1092-104. PubMed ID: 20435884
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Skp2 directs Myc-mediated suppression of p27kip1 yet has modest effects on Myc-driven lymphomagenesis.
    Old JB; Kratzat S; Hoellein A; Graf S; Nilsson JA; Nilsson L; Nakayama KI; Peschel C; Cleveland JL; Keller UB
    Mol Cancer Res; 2010 Mar; 8(3):353-62. PubMed ID: 20197382
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. miR-128b is a potent glucocorticoid sensitizer in MLL-AF4 acute lymphocytic leukemia cells and exerts cooperative effects with miR-221.
    Kotani A; Ha D; Hsieh J; Rao PK; Schotte D; den Boer ML; Armstrong SA; Lodish HF
    Blood; 2009 Nov; 114(19):4169-78. PubMed ID: 19749093
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Detection of gene copy number aberrations in mantle cell lymphoma by a single quantitative multiplex PCR assay: clinicopathological relevance and prognosis value.
    Jardin F; Picquenot JM; Parmentier F; Ruminy P; Cornic M; Penther D; Bertrand P; Lanic H; Cassuto O; Humbrecht C; Lemasle E; Wautier A; Bastard C; Tilly H
    Br J Haematol; 2009 Sep; 146(6):607-18. PubMed ID: 19594747
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Targeting ornithine decarboxylase impairs development of MYCN-amplified neuroblastoma.
    Rounbehler RJ; Li W; Hall MA; Yang C; Fallahi M; Cleveland JL
    Cancer Res; 2009 Jan; 69(2):547-53. PubMed ID: 19147568
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Expression of Foxo3a in non-Hodgkin's lymphomas is correlated with cell cycle inhibitor p27.
    Zhao Y; Fei M; Wang Y; Lu M; Cheng C; Shen A
    Eur J Haematol; 2008 Aug; 81(2):83-93. PubMed ID: 18363870
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Detection of somatic quantitative genetic alterations by multiplex polymerase chain reaction for the prediction of outcome in diffuse large B-cell lymphomas.
    Jardin F; Ruminy P; Kerckaert JP; Parmentier F; Picquenot JM; Quief S; Villenet C; Buchonnet G; Tosi M; Frebourg T; Bastard C; Tilly H
    Haematologica; 2008 Apr; 93(4):543-50. PubMed ID: 18287131
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Jun activation domain-binding protein 1 negatively regulate p27 kip1 in non-Hodgkin's lymphomas.
    Wang Y; Fei M; Cheng C; Zhang D; Lu J; He S; Zhao Y; Wang Y; Shen A
    Cancer Biol Ther; 2008 Mar; 7(3):460-7. PubMed ID: 18285702
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Prognostic implication of p27 expression in primary central nervous system lymphoma.
    Kunishio K; Nagao S
    Brain Tumor Pathol; 2006 Oct; 23(2):77-81. PubMed ID: 18095123
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Myc targets Cks1 to provoke the suppression of p27kip1, proliferation and lymphomagenesis.
    Keller UB; Old JB; Dorsey FC; Nilsson JA; Nilsson L; MacLean KH; Chung L; Yang C; Spruck C; Boyd K; Reed SI; Cleveland JL
    EMBO J; 2007 May; 26(10):2562-74. PubMed ID: 17464290
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.